摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

O-methylhalfordinol | 33864-03-8

中文名称
——
中文别名
——
英文名称
O-methylhalfordinol
英文别名
3-[5-(4-methoxy-phenyl)-oxazol-2-yl]-pyridine;3-(5-(4-methoxyphenyl)oxazol-2-yl)pyridine;methylhalofordinol;2--5-(4-methoxy-phenyl)-oxazol;O-Methyl-halfordinol;O-Methylaegelenin;Pyridine, 3-(5-(p-methoxyphenyl)-2-oxazolyl)-;5-(4-methoxyphenyl)-2-pyridin-3-yl-1,3-oxazole
O-methylhalfordinol化学式
CAS
33864-03-8
化学式
C15H12N2O2
mdl
——
分子量
252.272
InChiKey
LHPXYPROPRFEQE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    99-100 °C
  • 沸点:
    446.0±55.0 °C(Predicted)
  • 密度:
    1.182±0.06 g/cm3(Predicted)
  • 物理描述:
    Solid

计算性质

  • 辛醇/水分配系数(LogP):
    2.6
  • 重原子数:
    19
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.07
  • 拓扑面积:
    48.2
  • 氢给体数:
    0
  • 氢受体数:
    4

安全信息

  • 海关编码:
    2934999090

SDS

SDS:c979ef6a83e31fe026b7b4eac3cb0ddc
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    O-methylhalfordinol三溴化硼 作用下, 以 二氯甲烷 为溶剂, 反应 18.0h, 生成 4-[2-(3-吡啶基)-5-恶唑基]苯酚
    参考文献:
    名称:
    Structure–Activity Relationships of New Natural Product-Based Diaryloxazoles with Selective Activity against Androgen Receptor-Positive Breast Cancer Cells
    摘要:
    Targeted therapies for ER+/PR+ and HER2-amplified breast cancers have improved patient survival, but there are no therapies for triple negative breast cancers (TNBC) that lack expression of estrogen and progesterone receptors (ER/PR), or amplification or overexpression of HER2. Gene expression profiling of TNBC has identified molecular subtypes and representative cell lines. An extract of the Texas native plant Amyris texana was found to have selective activity against MDA-MB-453 cells, a model of the luminal androgen receptor (LAR) subtype of TNBC. Bioassay-guided fractionation identified two oxazole natural products with selective activity against this cell line. Conducted analog synthesis and structure activity relationship studies provided analogs with more potent and selective activity against two LAR. subtype cell line models, culminating in the discovery of compound 30 (CIDD-0067106). Lead compounds discovered have potent and selective antiproliferative activities, and mechanisms of action studies show they inhibit the activity of the mTORC1 pathway.
    DOI:
    10.1021/acs.jmedchem.7b01228
  • 作为产物:
    参考文献:
    名称:
    Combinatorial discovery of novel fluorescent dyes based on Dapoxyl™
    摘要:
    We have developed a combinatorial method for the fast and effective synthesis of a library based on a known fluorescent dye, Dapoxyl(TM) using parallel solution-phase chemistry. By screening the 140 new compounds using fluorescence-based assays, we identified three new fluorescent dyes with novel properties. (C) 2002 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0040-4039(02)00999-1
点击查看最新优质反应信息

文献信息

  • Inhibiting G Protein Coupled Receptor 6 Kinase Polypeptides
    申请人:Mayo Foundation for Medical Educational and Research
    公开号:US20140309185A1
    公开(公告)日:2014-10-16
    This document relates to inhibitors of G protein coupled receptor 6 kinase (GRK6) polypeptides as well as methods and materials for using such inhibitors to treat hematological malignancies, inflammation diseases, and autoimmune disorders.
    这份文件涉及G蛋白偶联受体6激酶(GRK6)多肽抑制剂,以及利用这些抑制剂治疗血液恶性肿瘤、炎症性疾病和自身免疫性疾病的方法和材料。
  • Certain azoles exhibiting ATP-utilizing enzyme inhibitory activity, compositions, and uses thereof
    申请人:Mendoza Serafin Jose
    公开号:US20080015193A1
    公开(公告)日:2008-01-17
    Certain oxazole-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, methods of using compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions comprising compounds exhibiting ATP-utilizing enzyme inhibitory activity, are disclosed.
    本发明涉及一些呈现出ATP利用酶抑制活性的噁唑基化合物,使用呈现出ATP利用酶抑制活性的化合物的方法,以及包含呈现出ATP利用酶抑制活性的化合物的组合物。
  • Anti-adipogenic action of a novel oxazole derivative through activation of AMPK pathway
    作者:Tripti Mishra、Sanchita Gupta、Prashant Rai、Nilesh Khandelwal、Mohit Chourasiya、Vinita Kushwaha、Astha Singh、Salil Varshney、Anil Nilkanth Gaikwad、Tadigoppula Narender
    DOI:10.1016/j.ejmech.2023.115895
    日期:2023.12
    other environmental factors. Both natural and synthetic heterocyclic compounds, especially oxazoles, represent an interesting group of compounds and have gained much attention due to their remarkable biological activities. Therefore, a library of 3,3-DMAH (3,3-dimethylallylhalfordinol) inspired N-alkylated oxazole bromide salts with varied substitutions were prepared and screened using the 3T3-L1 model
    肥胖是一种慢性疾病,其病因有多种,包括遗传、医学、饮食和其他环境因素。天然和合成的杂环化合物,尤其是恶唑,代表了一组有趣的化合物,并因其显着的生物活性而受到广泛关注。因此,利用叙利亚仓鼠脂肪生成的3T3-L1模型和HFD诱导的肥胖模型,制备并筛选了具有不同取代基的3,3-DMAH(3,3-二甲基烯丙基啶醇)启发的N-烷基化恶唑化盐文库。合成系列中的几种化合物对 3T3-L1 前脂肪细胞的分化表现出显着的抗脂肪形成潜力。化合物19e显示出所有化合物中最有效的活性,并被选择用于进一步研究。化合物19e抑制3T3-L1细胞的有丝分裂克隆扩张,并通过AMPK激活提高分化早期细胞的线粒体耗氧率。19e还改善了高热量饮食喂养的叙利亚仓鼠的血脂异常。因此,化合物19e可以作为对抗脂肪生成和血脂异常模型的潜在先导物质,并且可以进一步研究以确认其作为候选药物的重要性。
  • Electrochemical construction of 2,5-diaryloxazoles via N–H and C(sp3)-H functionalization
    作者:Tong Li、Leping Pan、Yan Zhang、Jihu Su、Kai Li、Kuiliang Li、Hu Chen、Qi Sun、Zhiyong Wang
    DOI:10.1016/j.cclet.2023.108897
    日期:2024.4
    An efficient NH and C(sp)-H functionalization of aryl ketones with benzylamines/amino acids was developed under mild conditions by virtue of anodic oxidation. A variety of functionalized 2,5-diaryloxazoles were obtained with good to excellent yields. Moreover, some important natural products can be prepared by this method. The reaction features a broad substrate scope, scalability, metal-free and chemical
    通过阳极氧化,在温和条件下开发了芳基酮与苄胺/氨基酸的有效 NH 和 C(sp)-H 官能化。以良好至优异的收率获得了多种官能化的2,5-二芳基恶唑。此外,一些重要的天然产物可以通过该方法制备。该反应具有底物范围广、可扩展、无属、无化学氧化剂等特点。
  • Inhibiting G protein coupled receptor 6 kinase polypeptides
    申请人:Mayo Foundation for Medical Education and Research
    公开号:US10252984B2
    公开(公告)日:2019-04-09
    This document relates to inhibitors of G protein coupled receptor 6 kinase (GRK6) polypeptides as well as methods and materials for using such inhibitors to treat hematological malignancies, inflammation diseases, and autoimmune disorders.
    本文件涉及 G 蛋白偶联受体 6 激酶(GRK6)多肽抑制剂以及使用这种抑制剂治疗血液恶性肿瘤、炎症疾病和自身免疫性疾病的方法和材料。
查看更多